The most current resources for a changing profession. PharmacyLibrary gives you access to APhA’s leading content including 45+ digital books, PharmacotherapyFirst and the Cultural Toolkit all at your fingertips.

Learn more today  

APhA’s Learning Library

We’re excited to announce the launch of the new APhA Learning Library! This new platform will make it easier than ever for you to get the education you need. Read about some key highlights of our new system.

Learn more  

Share your Workplace Experiences

The Pharmacy Workplace and Well-being Reporting (PWWR) tool offers a secure and confidential platform for the entire pharmacy community to anonymously share both positive and negative workplace experiences.

Submit to PWWR  


Featured Education

Upcoming Events

Practice Resources

Tools and resources to support your practice

Access Now  


Latest from APhA

View CEO Blog

Dream stealers and dream keepers—A message for graduates, and perhaps all of us

As I write this week’s blog, I’m preparing for commencement addresses at two schools of pharmacy: Auburn University’s Harrison School of Pharmacy, and Howard University School of Pharmacy. Walking around college campuses this time of year reminds me of the hope of the future, and as I strolled around the Loveliest Village on the Plains it hit me that there is a stark contrast between this week and next month for these graduates.


APhA announces results of 2024 Board elections

WASHINGTON, DC—Today the American Pharmacists Association (APhA) announced the election of Magaly Rodriguez de Bittner, PharmD, FNAP, FAPhA, of Pasadena, MD, as 2025–2026 APhA president-elect. Rodrigeuz de Bittner will succeed Randy P. McDonough, BS, PharmD, MS, BCGP, BCPS, RPh, of Iowa City, IA, in the office of APhA president on March 30, 2026, at the conclusion of the 2026 APhA Annual Meeting & Exposition in Los Angeles, CA.


Pharmacy news

View all news

Fentanyl tablet seizures have quadrupled in 6 years

Law enforcement seizures of illicit fentanyl increased dramatically in number and size between 2017 and 2023 in the United States, especially in tablet form, according to a new study funded by the NIH National Institute on Drug Abuse. The findings, published online in International Journal of Drug Policy on May 13, 2024, highlight the illicit drug supply and the risk of tablets not coming from a pharmacy.

Coming off GLP-1s slowly could be key to preventing weight regain

Despite concerns about patients regaining weight after stopping GLP-1 receptor agonists like semaglutide and tirzepatide, new research suggests that such gains aren’t necessarily the case. The key, the findings suggest, lies in gradually weaning off the drug instead of withdrawing abruptly and completely, and then continuing to make healthy choices.